The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: Comparison with cationic antimicrobial peptides and lipopeptides
Open accessAbstract
With the steady rise in the number of antibiotic-resistant Gram-positive pathogens, it has become increasingly important to find new antibacterial agents which are highly active and have novel and diversified mechanisms of action. Two classes will be discussed here: the cationic antimicrobial peptides, which are amphiphilic in nature, targeting membranes and increasing their permeability; and lipopeptides, which consist of linear or cyclic peptides with an N-terminus that is acylated with a fatty acid side chain. One member of the cyclic lipopeptide family, the anionic molecule daptomycin, has been extensively studied and is the major focus of this review. Models will be presented on its mode of action and comparisons will be made to the known modes of action of cationic antimicrobial peptides and other lipopeptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shai, Y. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00200-x · Cited by 1,869
Geiger, T., & Clarke, S. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75855-4 · Cited by 1,311
Hancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190
Self-citationMatsuzaki, K. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00197-2 · Cited by 1,010
Cationic peptides: effectors in innate immunity and novel antimicrobials
Hancock, R. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00092-5 · Cited by 978 · cited 3×
“Despite the diversity in the amino acid sequence and the structural classes (i.e., β -sheets, α -helices, loops and extended structures [12]) of antimicrobial peptides, with over 700 known to date, they all share a common three-dimensional arrangement.”
BackgroundInfluentialSelf-citationTrends in antimicrobial drug development: Implications for the future
Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867
Polymyxin and Related Peptide Antibiotics
Storm, D. R., Rosenthal, K. S., & Swanson, P. E. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003451 · Cited by 759
Action of Antimicrobial Peptides: Two-State Model
Huang, H. W. (2000) · Biochemistry · doi:10.1021/bi000946l · Cited by 740
Wu, M., Maier, E., Benz, R., & Hancock, R. E. W. (1999) · Biochemistry · doi:10.1021/bi9826299 · Cited by 736
Self-citationArbeit, R. D., Maki, D., Tally, F. P., Campanaro, E., Eisenstein, B. I., & Daptomycin 98-01 and 99-01 Investigators (2004) · Clinical Infectious Diseases · doi:10.1086/420818 · Cited by 689
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Silverman, J. A., Perlmutter, N. G., & Shapiro, H. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2538-2544.2003 · Cited by 656
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh546 · Cited by 561
Mechanism of Lipid Bilayer Disruption by the Human Antimicrobial Peptide, LL-37
Henzler Wildman, K. A., Lee, D.-K., & Ramamoorthy, A. (2003) · Biochemistry · doi:10.1021/bi0273563 · Cited by 518
Host defense peptides as new weapons in cancer treatment
Papo, N., & Shai, Y. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4560-2 · Cited by 501
Kragol, G., Lovas, S., Varadi, G., Condie, B. A., Hoffmann, R., & Otvos, L. (2001) · Biochemistry · doi:10.1021/bi002656a · Cited by 491
Crystallization of Antimicrobial Pores in Membranes: Magainin and Protegrin
Yang, L., Weiss, T. M., Lehrer, R. I., & Huang, H. W. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76448-4 · Cited by 437
Hallock, K. J., Lee, D.-K., & Ramamoorthy, A. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)70031-9 · Cited by 371
Zhang, L., Dhillon, P., Yan, H., Farmer, S., & Hancock, R. E. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3317-3321.2000 · Cited by 349
Self-citationDevelopment of daptomycin for Gram-positive infections
Tally, F. P., & DeBruin, M. F. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.4.523 · Cited by 321
Echinocandins: a new class of antifungal
Denning, D. W. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf045 · Cited by 300
Structural Transitions as Determinants of the Action of the Calcium-Dependent Antibiotic Daptomycin
Jung, D., Rozek, A., Okon, M., & Hancock, R. E. W. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.020 · Cited by 297
Self-citationAntimicrobial Peptides in Health and Disease
Zasloff, M. (2002) · New England Journal of Medicine · doi:10.1056/nejme020106 · Cited by 296
Perturbation of the Hydrophobic Core of Lipid Bilayers by the Human Antimicrobial Peptide LL-37
Henzler-Wildman, K. A., Martinez, G. V., Brown, M. F., & Ramamoorthy, A. (2004) · Biochemistry · doi:10.1021/bi036284s · Cited by 296
Evidence for Membrane Thinning Effect as the Mechanism for Peptide-Induced Pore Formation
Chen, F.-Y., Lee, M.-T., & Huang, H. W. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)75103-0 · Cited by 295
Mechanisms of action of newer antibiotics for Gram-positive pathogens
Hancock, R. E. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70051-7 · Cited by 295
Self-citationTigecycline: what is it, and where should it be used?
Livermore, D. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki291 · Cited by 261
Moudgal, V., Little, T., Boikov, D., & Vazquez, J. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.767-769.2005 · Cited by 242
Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus
Hayden, M. K., Rezai, K., Hayes, R. A., Lolans, K., Quinn, J. P., & Weinstein, R. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5285-5287.2005 · Cited by 241
Resistance Studies with Daptomycin
Silverman, J. A., Oliver, N., Andrew, T., & Li, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1799-1802.2001 · Cited by 234
Mecke, A., Lee, D.-K., Ramamoorthy, A., Orr, B. G., & Banaszak Holl, M. M. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.062596 · Cited by 216
Membrane Composition Determines Pardaxin's Mechanism of Lipid Bilayer Disruption
Hallock, K. J., Lee, D.-K., Omnaas, J., Mosberg, H. I., & Ramamoorthy, A. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)75226-0 · Cited by 207
Membrane Thinning Effect of the β-Sheet Antimicrobial Protegrin
Heller, W. T., Waring, A. J., Lehrer, R. I., Harroun, T. A., Weiss, T. M., Yang, L., & Huang, H. W. (2000) · Biochemistry · doi:10.1021/bi991892m · Cited by 189
Bierbaum, G., & Sahl, H.-G. (1985) · Archives of Microbiology · doi:10.1007/bf00408067 · Cited by 174
In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic
Eliopoulos, G. M., Willey, S., Reiszner, E., Spitzer, P. G., Caputo, G., & Moellering, R. C. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.4.532 · Cited by 173
Structure and Orientation of Pardaxin Determined by NMR Experiments in Model Membranes
Porcelli, F., Buck, B., Lee, D.-K., Hallock, K. J., Ramamoorthy, A., & Veglia, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405454200 · Cited by 170
Avrahami, D., & Shai, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312260200 · Cited by 167
Cationic Peptides: Distribution and Mechanisms of Resistance
Devine, D., & Hancock, R. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023395501 · Cited by 160
Self-citationSigmoidal Concentration Dependence of Antimicrobial Peptide Activities: A Case Study on Alamethicin
Chen, F.-Y., Lee, M.-T., & Huang, H. W. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)75452-0 · Cited by 159
Barry, A. L., FUCHS, P. C., & Brown, S. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1919-1922.2001 · Cited by 158
Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032
Allen, N. E., Hobbs, J. N., & Alborn, W. E. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.7.1093 · Cited by 151
The need for new therapeutic agents: what is in the pipeline?
SHAH, P. M. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01141.x · Cited by 147
Novel antibacterial agents for the treatment of serious Gram-positive infections
Abbanat, D., Macielag, M. J., & Bush, K. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.3.379 · Cited by 140
Promotion of Peptide Antimicrobial Activity by Fatty Acid Conjugation
Chu-Kung, A. F., Bozzelli, K. N., Lockwood, N. A., Haseman, J. R., Mayo, K. H., & Tirrell, M. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0341573 · Cited by 128
Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance
Brazas, M. D., & Hancock, R. E. W. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03566-x · Cited by 127
Self-citationEchinocandins and pneumocandins--a new antifungal class with a novel mode of action
Denning, D. W. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.5.611 · Cited by 126
Wakabayashi, H., Matsumoto, H., Hashimoto, K., Teraguchi, S., Takase, M., & Hayasawa, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1267 · Cited by 104
Avrahami, D., & Shai, Y. (2003) · Biochemistry · doi:10.1021/bi035142v · Cited by 96
Update on linezolid: the first oxazolidinone antibiotic
Wilcox, M. H. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.13.2315 · Cited by 75
Daptomycin-Resistant Enterococcus faecium in a Patient With Acute Myeloid Leukemia
Long, J. K., Choueiri, T. K., Hall, G. S., Avery, R. K., & Sekeres, M. A. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.9.1215 · Cited by 71
Buffy, J. J., McCormick, M. J., Wi, S., Waring, A. J., Lehrer, R. I., & Hong, M. (2004) · Biochemistry · doi:10.1021/bi036243w · Cited by 64
Mak, P., Pohl, J., Dubin, A., Reed, M. S., Bowers, S., Fallon, M. T., & Shafer, W. M. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00245-5 · Cited by 64
Cationic antimicrobial peptides ? an update
Zhang, L., & Falla, T. J. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.2.97 · Cited by 54
The Antimicrobial Armamentarium: Evaluating Current and Future Treatment Options
Bosso, J. A. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.10part2.55s · Cited by 42
The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci
Andrew, J. H., Wale, M. C. J., Wale, L. J., et al. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.2.213 · Cited by 40
Lohner, K., Staudegger, E., Prenner, E. J., Lewis, R. N. A. H., Kriechbaum, M., Degovics, G., & McElhaney, R. N. (1999) · Biochemistry · doi:10.1021/bi9913101 · Cited by 39
On Glumamycin, a New Antibiotic. VI. An Approach to the Amino Acid Sequence
Fujino, M. (1965) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.38.517 · Cited by 19
In vitro evaluation of the cyclic lipopeptide LY 146032 (daptomycin).
Botha, P., Heerden, C. J. V., Vorster, E., et al. (1988) · PubMed · Cited by 3
Structure determination of peptides with antimicrobial action
Bunkòczi, G. (2004) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-2187 · Cited by 2
Cited by
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
Natural products: An evolving role in future drug discovery
Mishra, B. B., & Tiwari, V. K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.057 · Cited by 860
Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment
Shaikh, S., Fatima, J., Shakil, S., Rizvi, S. M. D., & Kamal, M. A. (2015) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2014.08.002 · Cited by 758
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria
Hale, J. D., & Hancock, R. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.6.951 · Cited by 549
Self-citationGuilhelmelli, F., Vilela, N., Albuquerque, P., Derengowski, L. D. S., Silva-Pereira, I., & Kyaw, C. M. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00353 · Cited by 546
Metadata
- Authors
- Straus, S. K., & Hancock, R. E. W.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 1758
- Issue
- 9
- Pages
- 1215-1223
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W1993287556
- Cited by
- 446
- References
- 58
- FWCI
- 12.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.